Table 1.
Patient demographics.
| All recurrence (n = 349) | Recur within 2 years (n = 213) | Recur after 2 years (n = 136) | P-value | |
|---|---|---|---|---|
| Survival after recurrence: months (median, IQR) | 11.2 (5.7–22.3) | 10.2 (5.2–19.9) | 14.3 (6.6–32.6) | 0.026 |
| Age: years (mean ± SD) | 55.4 ± 8.6 | 55.1 ± 8.7 | 54.1 ± 8.4 | 0.295 |
| Male (n, %) | 295 (84.5) | 181 (85) | 114 (83.8) | 0.890 |
| Cirrhosis (n, %) | 314 (90.0) | 189 (88.7) | 125 (91.9) | 0.434 |
| Diabetes mellitus (n, %) | 79 (22.6) | 51 (23.9) | 28 (20.6) | 0.549 |
| Hyperlipidemia (n, %) | 36 (10.3) | 22 (10.3) | 14 (10.3) | 1.000 |
| Alcohol use (n, %) | 16 (4.6) | 13 (6.1) | 3 (2.2) | 0.151 |
| HBV (n, %) | 262 (75.1) | 163 (76.5) | 99 (72.8) | 0.510 |
| HBV-medication use before transplant (n, %) | 173 (49.6) | 104 (48.8) | 69 (50.7) | 0.812 |
| HCV (n, %) | 150 (43.0) | 97 (45.5) | 53 (39.0) | 0.272 |
| HCV-medication use before transplant (n, %) | 39 (11.2) | 20 (9.4) | 19 (14.0) | 0.250 |
| Living donor (n, %) | 266 (76.2) | 163 (76.5) | 103 (75.7) | 0.968 |
| Transplantation period (n, %) | < 0.001 | |||
| Before 2008 | 112 (32.1) | 55 (25.8) | 57 (41.9) | |
| 2009–2012 | 134 (38.4) | 71 (33.3) | 63 (46.3) | |
| After 2013 | 103 (29.5) | 87 (40.9) | 16 (11.8) |
IQR, interquartile range; SD, standard deviation.